Neural stem cells (NSCs) sit at the heart of brain development, lifelong neurogenesis, and the brain’s capacity to respond to injury and disease. Their fate ...

Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

The Spanish scientist works at Altos Labs, a secretive US biotech company funded by billionaires seeking to eliminate the ...

A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center report that ...

About the speaker [More info]: Prof David Baker is the director of the Institute for Protein Design, a Howard Hughes Medical Institute Investigator, a professor of biochemistry, and an adjunct ...

Hyderabad: The CSIR-Centre for Cellular and Molecular Biology (CCMB) is hosting a five-day EMBO India Lecture Course titled ‘Structure, Function and Quality Control of Proteins in Cell Organelles.' ...

Add Yahoo as a preferred source to see more of our stories on Google. An early stage embryo. Dr Azelle Hawdon, Zenker Lab, Australian Regenerative Medicine Institute Most people have heard of stem ...

Biologist who won the Nobel prize for discovering that adult cells can be reprogrammed The exciting possibility that mature body cells, such as skin cells, might be transformed and used to repair ...

UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ones. The findings, ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced that the company presented preclinical data on its investigational ...

Humble skin cells can be reprogrammed into pluripotent stem cells. Credit: James Thomson Of all the obstacles faced by researchers trying to develop stem cell therapies, finding a noncontroversial ...